The results were also significant in a multifactorial analysis including tamoxifen treatment, lymph node status, tumor size, ER status, HER2 status, and SPF (HR = 3.69, [CI 95% 1.11–12.2], p = 0.033). This evidence concerns the gene ERBB2 and neoplasm.